Fehmi Keçe

Chapter 2 34 Table 1a. Continued. Author, year (study type) Number of patients and type of ablation device PAF (%) Preventive techniques AAD free survival (1 year) (%) Procedural and ablation time (min) Complications (%) Straube, 2016 (92) (multicenter observational) N=180 RF 100 N.A. 61 180 (p<0.001) 38 (P<0.001) - Cardiac Tamponade 2.5 - Stroke 0.6 - Transient PNP 0.6 - Vascular access 7.5 and severe bleeding 0.6 Wasserlauf, 2015 (96) (retrospective) N=100 RF 100 N.A. 61 284 (P<0.001) N.A. - Cardiac tamponade 4 - Vascular access 1 - Other: respiratory arrest during extubation 1 Only observational/retrospective studies and randomized clinical trials with n > 100 are included. in patients with paroxysmal atrial fibrillation, showing the use of different ablation devices, outcomes, the use of preventive techniques and complication rates. AAD= anti-arrhythmic drugs, DC=dormant conduction, IQR=interquartile range, PAF=paroxysmal atrial fibrillation, PNP=phrenic nerve palsy, RF=radiofrequency ablation, RFA=radiofrequency advanced with CF technology and TIA=Transient ischemic attack. P-values indicated significant differences between catheters from the same technology (table 1) or between catheters from different technologies (table 1 vs. table 2).